Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dare Bioscience (DARE) Return on Sales (2016 - 2025)

Dare Bioscience (DARE) has disclosed Return on Sales for 7 consecutive years, with 1623.41% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Sales fell 151112.0% year-over-year to 1623.41%, compared with a TTM value of 305.39% through Sep 2025, up 31780.0%, and an annual FY2024 reading of 2396.92%, down 238590.0% over the prior year.
  • Return on Sales was 1623.41% for Q3 2025 at Dare Bioscience, down from 180.8% in the prior quarter.
  • Across five years, Return on Sales topped out at 180.8% in Q2 2025 and bottomed at 1623.41% in Q3 2025.
  • Average Return on Sales over 4 years is 204.46%, with a median of 3.14% recorded in 2022.
  • Peak annual rise in Return on Sales hit 50879bps in 2025, while the deepest fall reached -151112bps in 2025.
  • Year by year, Return on Sales stood at 3.14% in 2022, then increased by 9bps to 2.86% in 2023, then soared by 3060bps to 84.66% in 2024, then plummeted by -2018bps to 1623.41% in 2025.
  • Business Quant data shows Return on Sales for DARE at 1623.41% in Q3 2025, 180.8% in Q2 2025, and 179.28% in Q1 2025.